What if Bevacizumab was discontinued! Can IMpower130 be exchanged for IMpower150 for advanced non-squamous NSCLC patients with PD-L1 <50% and without genomic mutations?
Crossref DOI link: https://doi.org/10.30574/wjarr.2021.11.2.0398
Published Online: 2021-08-30
Update policy: https://doi.org/10.30574/wjarr.ourcrossmarkpolicy
Khaled Elmahdi Omran,
